✦ LIBER ✦

Angiotensin-converting enzyme inhibitors: optimal management of cardiovascular risk

✍ Scribed by Mori J. Krantz

Book ID: 113976934
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 30 KB
Volume: 92
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(03)00855-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular drugs in children: Angiot

Cardiovascular drugs in children: Angiotensin-converting enzyme inhibitors

✍ Adam Schneeweiss 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 717 KB

Angiotensin-converting enzyme 2 polymorp

Angiotensin-converting enzyme 2 polymorphisms and cardiovascular risk

✍ Grace, J. A.; Burrell, L. M.; Patel, S. K. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Cardiovascular Events in Hypertension Tr

Cardiovascular Events in Hypertension Trials of Angiotensin-Converting Enzyme Inhibitors

✍ William J. Elliott 📂 Article 📅 2005 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 348 KB

Angiotensin-converting enzyme inhibitors

Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis

✍ Kenneth J. Mukamal; Sanjay Ghimire; Rudra Pandey; Gale S. Fiarman; Shiva Gautam 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Angiotensin-converting enzyme inhibitors

Angiotensin-converting enzyme inhibitors: first-line agents in cardiovascular protection?

✍ Ruschitzka, F.; Taddei, S. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 52 KB

Management of angiotensin-converting enz

Management of angiotensin-converting enzyme inhibitor–induced angioedema

✍ Samer Al-Khudari; Michael J. Loochtan; Edward Peterson; Kathleen L. Yaremchuk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

## Abstract ## Objectives/Hypothesis: To develop and validate a clinical algorithm for management of patients with angiotensin‐converting enzyme inhibitor–induced angioedema (AIIA). ## Study Design: Prospective cohort observational study. ## Methods: Over 1 year, 40 patients with AIIA were eva